BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71
86 results:

  • 1. PHRF1 Promotes Cell Invasion by Modulating SOX4 Expression in Colorectal cancer HCT116-p53
    Lin HW; Shih TW; Amanna A; Chang MS
    Anticancer Res; 2023 Dec; 43(12):5437-5446. PubMed ID: 38030167
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Population Pharmacokinetics of myl-1402O, a Proposed Biosimilar to Bevacizumab and Reference Product (Avastin
    Owen JS; Rackley RJ; Hummel MA; Roepcke S; Huang H; Liu M; Idris TA; Murugesan SMN; Marwah A; Loganathan S; Ranganna G; Barve A; Waller CF; Socinski MA
    Eur J Drug Metab Pharmacokinet; 2023 Nov; 48(6):675-689. PubMed ID: 37792130
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Promyelocytic leukemia protein regulates angiogenesis and epithelial-mesenchymal transition to limit metastasis in MDA-MB-231 breast cancer cells.
    Vogiatzoglou AP; Spanou S; Sachini N; Drakos E; Nikolaou C; Makatounakis T; Kretsovali A; Papamatheakis J
    Mol Oncol; 2023 Oct; 17(10):2090-2108. PubMed ID: 37518985
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Immune reconstitution inflammatory syndrome drives emergence of HIV drug resistance from multiple anatomic compartments in a person living with HIV.
    Lisco A; Lange C; Manion M; Kuriakose S; Dewar R; Gorelick RJ; Huik K; Yu Q; Hammoud DA; Smith BR; Muranski P; Rehm C; Sherman BT; Sykes C; Lindo N; Ye P; Bricker KM; Keele BF; Fennessey CM; Maldarelli F; Sereti I
    Nat Med; 2023 Jun; 29(6):1364-1369. PubMed ID: 37322122
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Convergence of YAP/TAZ, TEAD and TP63 activity is associated with bronchial premalignant severity and progression.
    Ning B; Tilston-Lunel AM; Simonetti J; Hicks-Berthet J; Matschulat A; Pfefferkorn R; Spira A; Edwards M; Mazzilli S; Lenburg ME; Beane JE; Varelas X
    J Exp Clin Cancer Res; 2023 May; 42(1):116. PubMed ID: 37150829
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Interrogating the precancerous evolution of pathway dysfunction in lung squamous cell carcinoma using XTABLE.
    Roberts M; Ogden J; Hossain ASM; Chaturvedi A; Kerr ARW; Dive C; Beane JE; Lopez-Garcia C
    Elife; 2023 Mar; 12():. PubMed ID: 36892933
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Killing Two Birds With One Stone: Effective Control of Both Non-Small Cell lung cancer and Progressive Multifocal Leukoencephalopathy With Atezolizumab, A Case Report.
    Lambert N; El Moussaoui M; Ritacco C; Moïse M; Paulus A; Delvenne P; Baron F; Sadzot B; Maquet P
    Front Immunol; 2022; 13():889148. PubMed ID: 35592313
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. myl-1402O: A Bevacizumab Biosimilar.
    Lee A
    Target Oncol; 2022 Jan; 17(1):85-88. PubMed ID: 34910269
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of a prognostic immune-related signature for small cell lung cancer.
    Xie Q; Chu H; Yi J; Yu H; Gu T; Guan Y; Liu X; Liang J; Li Y; Wang J
    Cancer Med; 2021 Dec; 10(24):9115-9128. PubMed ID: 34741430
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (pml).
    Zhang J; Zhai J; Wong CC; Chen H; Wang X; Ji J; Yu J
    Oncogene; 2021 Dec; 40(49):6641-6652. PubMed ID: 34625711
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Elevated T cell repertoire diversity is associated with progression of lung squamous cell premalignant lesions.
    Maoz A; Merenstein C; Koga Y; Potter A; Gower AC; Liu G; Zhang S; Liu H; Stevenson C; Spira A; Reid ME; Campbell JD; Mazzilli SA; Lenburg ME; Beane J
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34580161
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Analytical similarity assessment of myl-1402O to reference Bevacizumab.
    Goyal P; Vats B; Subbarao M; Honnappa CG; Kabadi P; Rohil S; Bera A; Mehta GR; Pai H; Adhikari L; Tagore R; Sharma S; Venkatachala R; Nair P; Annegowda S; Sahu A; Trivedi S; Shastri N; Gokhale Y; Thomas R; Thakur A; Mohan D; Rao K U; Melarkode R; Ullanat R
    Expert Opin Biol Ther; 2022 Feb; 22(2):271-298. PubMed ID: 34465264
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The Updating of Biological Functions of Methyltransferase SETDB1 and Its Relevance in lung cancer and Mesothelioma.
    Yuan L; Sun B; Xu L; Chen L; Ou W
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299035
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future.
    Hofman P; Ilié M; Chamorey E; Brest P; Schiappa R; Nakache V; Antoine M; Barberis M; Begueret H; Bibeau F; Bonnetaud C; Boström P; Brousset P; Bubendorf L; Carvalho L; Cathomas G; Cazes A; Chalabreysse L; Chenard MP; Copin MC; Côté JF; Damotte D; de Leval L; Delongova P; Thomas de Montpreville V; de Muret A; Dema A; Dietmaier W; Evert M; Fabre A; Forest F; Foulet A; Garcia S; Garcia-Martos M; Gibault L; Gorkiewicz G; Jonigk D; Gosney J; Hofman A; Kern I; Kerr K; Kossai M; Kriegsmann M; Lassalle S; Long-Mira E; Lupo A; Mamilos A; Matěj R; Meilleroux J; Ortiz-Villalón C; Panico L; Panizo A; Papotti M; Pauwels P; Pelosi G; Penault-Llorca F; Pop O; Poté N; Cajal SRY; Sabourin JC; Salmon I; Sajin M; Savic-Prince S; Schildhaus HU; Schirmacher P; Serre I; Shaw E; Sizaret D; Stenzinger A; Stojsic J; Thunnissen E; Timens W; Troncone G; Werlein C; Wolff H; Berthet JP; Benzaquen J; Marquette CH; Hofman V; Calabrese F
    ESMO Open; 2021 Feb; 6(1):100024. PubMed ID: 33399086
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Therapy-related acute promyelocytic leukemia with complex karyotype accompanied by cryptic pml/RARA on chromosome 15 by metaphase FISH].
    Kashima E; Sugimoto Y; Nato Y; Ino K; Tawara I; Masuya M; Katayama N
    Rinsho Ketsueki; 2020; 61(11):1577-1583. PubMed ID: 33298649
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. OTUD5 cooperates with TRIM25 in transcriptional regulation and tumor progression via deubiquitination activity.
    Li F; Sun Q; Liu K; Zhang L; Lin N; You K; Liu M; Kon N; Tian F; Mao Z; Li T; Tong T; Qin J; Gu W; Li D; Zhao W
    Nat Commun; 2020 Aug; 11(1):4184. PubMed ID: 32826889
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. PHRF1 promotes migration and invasion by modulating ZEB1 expression.
    Lee JY; Fan CC; Chou NL; Lin HW; Chang MS
    PLoS One; 2020; 15(7):e0236876. PubMed ID: 32730336
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Successful Treatment of Therapy-related Acute Promyelocytic Leukemia with All-trans-retinoic acid Following Epirubicin for Hepatocellular Carcinoma and Docetaxel and Pembrolizumab Therapies for lung Carcinoma: A Triple Malignancy Case.
    Suzuki R; Kawai H; Furuya D; Akashi H; Ogawa Y; Kawada H; Ando K
    Tokai J Exp Clin Med; 2020 Jul; 45(2):92-96. PubMed ID: 32602108
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. An NRAS mutation in primary malignant melanoma of the lung: a case report.
    Hibiya T; Tanaka M; Matsumura M; Aoki A; Ikegami T; Okudela K; Kawano N; Ohashi K
    Diagn Pathol; 2020 Feb; 15(1):11. PubMed ID: 32028967
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
    Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
    BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.